暂无推荐供应商。我要出现这里
化源商城直购
IRAK4:1.5 nM (IC50)
[1]. Sabnis RW. Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases. ACS Med Chem Lett. 2022 Feb 28;13(3):336-337.